{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:12:36Z","timestamp":1790871156793,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biologicals.2025.101820","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:02:36Z","timestamp":1738126956000},"page":"101820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Serum reactivity analysis with inactivated GVII-matched vaccine\u2014Payavax G79\u00ae: Comparison of B-cell epitopes in NDV-vaccine strains"],"prefix":"10.1016","volume":"90","author":[{"given":"Parisa","family":"Jamour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-2237","authenticated-orcid":false,"given":"Maryam","family":"Shafaati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Gholizadeh","family":"Gigloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa Sheini","family":"Mehrabzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Towhid","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Lotfinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Majidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2025.101820_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.vas.2024.100348","article-title":"Evaluation of the Newcastle disease virus genotype VII\u2013mismatched vaccines in SPF chickens: a challenge efficacy study","volume":"24","author":"Hassanzadeh","year":"2024","journal-title":"Veterinary Animal Sci."},{"key":"10.1016\/j.biologicals.2025.101820_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106068","article-title":"Comparative pathogenicity of a genotype XXI. 1.2 pigeon Newcastle disease virus isolate in pigeons and chickens","volume":"178","author":"Hossain","year":"2023","journal-title":"Microb Pathog"},{"issue":"1\u20132","key":"10.1016\/j.biologicals.2025.101820_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virusres.2005.11.009","article-title":"Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications","volume":"120","author":"Czegl\u00e9di","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2025.101820_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcpa.2021.05.003","article-title":"Efficacy of vaccination against infection with velogenic Newcastle disease virus genotypes VI and VII 1.1 strains in Japanese quails","volume":"186","author":"Abd-Ellatieff","year":"2021","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.biologicals.2025.101820_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103917","article-title":"Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus","volume":"74","author":"Dimitrov","year":"2019","journal-title":"Infect Genet Evol"},{"issue":"6","key":"10.1016\/j.biologicals.2025.101820_bib6","first-page":"1794","article-title":"Molecular identification and phylogenetic study based on the fusion gene of newcastle disease virus isolated from broiler poultry farms in markazi province, Iran","volume":"78","author":"Vahidi","year":"2023","journal-title":"Archives of Razi Institute"},{"issue":"3\u20134","key":"10.1016\/j.biologicals.2025.101820_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vetmic.2009.09.020","article-title":"Phylogenetic characterization of Newcastle disease virus isolated in the mainland of China during 2001\u20132009","volume":"141","author":"Rui","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.biologicals.2025.101820_bib8","series-title":"Veterinary research forum","article-title":"Introduction of a Newcastle disease virus challenge strain (sub-genotype VII. 1.1) isolated in Iran","author":"Khabiri","year":"2023"},{"issue":"8","key":"10.1016\/j.biologicals.2025.101820_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/v9080225","article-title":"Effects of the HN antigenic difference between the vaccine strain and the challenge strain of Newcastle disease virus on virus shedding and transmission","volume":"9","author":"Liu","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.biologicals.2025.101820_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13567-022-01118-w","article-title":"Current situation and future direction of Newcastle disease vaccines","volume":"53","author":"Hu","year":"2022","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.biologicals.2025.101820_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/tbed.14121","article-title":"Comparison of genomic and antigenic properties of Newcastle Disease virus genotypes II, XXI and VII from Egypt do not point to antigenic drift as selection marker","volume":"69","author":"Naguib","year":"2022","journal-title":"Transbound Emerg Dis"},{"issue":"1\u20132","key":"10.1016\/j.biologicals.2025.101820_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vetmic.2012.05.003","article-title":"Newcastle disease virus outbreaks: vaccine mismatch or inadequate application?","volume":"160","author":"Dortmans","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.biologicals.2025.101820_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","article-title":"Newcastle disease vaccines\u2014a solved problem or a continuous challenge?","volume":"206","author":"Dimitrov","year":"2017","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.biologicals.2025.101820_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dci.2013.06.007","article-title":"Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses","volume":"41","author":"Miller","year":"2013","journal-title":"Dev Comp Immunol"},{"issue":"5","key":"10.1016\/j.biologicals.2025.101820_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s11250-019-01817-1","article-title":"NDV subgenotype VII(L) is currently circulating in commercial broiler farms of Iran, 2017-2018","volume":"51","author":"Molouki","year":"2019","journal-title":"Trop Anim Health Prod"},{"issue":"1","key":"10.1016\/j.biologicals.2025.101820_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13337-015-0299-z","article-title":"Molecular characterization and phylogenetic study of the fusion genes of Newcastle disease virus from the recent outbreaks in Ahvaz, Iran","volume":"27","author":"Boroomand","year":"2016","journal-title":"Virusdisease"},{"key":"10.1016\/j.biologicals.2025.101820_bib17","series-title":"Terrestrial manual 2021","year":"2021"},{"issue":"W1","key":"10.1016\/j.biologicals.2025.101820_bib18","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2025.101820_bib19","series-title":"Guide to graphics software tools","author":"Chen","year":"2007"},{"issue":"1","key":"10.1016\/j.biologicals.2025.101820_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"issue":"1","key":"10.1016\/j.biologicals.2025.101820_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines9010037","article-title":"Efficacy of a Turkey herpesvirus vectored Newcastle disease vaccine against genotype VII. 1.1 virus: challenge route affects shedding pattern","volume":"9","author":"Palya","year":"2021","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.biologicals.2025.101820_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13337-019-00537-2","article-title":"Genotypes II and VIId-based inactivated Newcastle disease vaccine reduces virus shedding","volume":"30","author":"Mahmoud","year":"2019","journal-title":"Virusdisease"},{"issue":"1","key":"10.1016\/j.biologicals.2025.101820_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vaccine.2016.11.048","article-title":"Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2025.101820_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1026296","article-title":"Genetic diversity of Newcastle disease viruses circulating in wild and synanthropic birds in Ukraine between 2006 and 2015","volume":"10","author":"Goraichuk","year":"2023","journal-title":"Front Vet Sci"},{"issue":"41","key":"10.1016\/j.biologicals.2025.101820_bib25","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2007.07.017","article-title":"Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge","volume":"25","author":"Miller","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2025.101820_bib26","series-title":"Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides","first-page":"138","author":"Reynolds","year":"2000"},{"key":"10.1016\/j.biologicals.2025.101820_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2023.110591","article-title":"Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX","volume":"259","author":"Liu","year":"2023","journal-title":"Vet Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.biologicals.2025.101820_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.01356-07","article-title":"Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to 2005","volume":"46","author":"Qin","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.biologicals.2025.101820_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines10010029","article-title":"Efficacy of the Newcastle disease virus genotype VII. 1.1-matched vaccines in commercial broilers","volume":"10","author":"Sultan","year":"2021","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.biologicals.2025.101820_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.14202\/vetworld.2019.677-683","article-title":"Prevalence, molecular typing, and antimicrobial resistance of bacterial pathogens isolated from ducks","volume":"12","author":"Eid","year":"2019","journal-title":"Vet World"},{"issue":"23","key":"10.1016\/j.biologicals.2025.101820_bib31","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/S0264-410X(03)00249-4","article-title":"Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines","volume":"21","author":"Maas","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2025.101820_bib32","series-title":"Veterinary research forum","article-title":"In silico prediction of B and T cell epitopes based on NDV fusion protein for vaccine development against Newcastle disease virus","author":"Hosseini","year":"2021"},{"key":"10.1016\/j.biologicals.2025.101820_bib33","article-title":"In silico design of epitope based peptide vaccine against virulent strains of hn-newcastle disease virus (NDV) in poultry species","volume":"4","author":"Osman","year":"2016","journal-title":"IJMCR: Int J Med Clin Res"},{"issue":"3","key":"10.1016\/j.biologicals.2025.101820_bib34","first-page":"61","article-title":"Immunoinformatics predication and in silico modeling of epitope-based peptide vaccine against virulent Newcastle disease viruses","volume":"4","author":"Badawi","year":"2016","journal-title":"Am J Infect Dis Microbiol"},{"issue":"3","key":"10.1016\/j.biologicals.2025.101820_bib35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.psj.2019.10.063","article-title":"Protective efficacy of the Newcastle disease virus genotype VII\u2013matched vaccine in commercial layers","volume":"99","author":"Sultan","year":"2020","journal-title":"Poultry Sci"},{"issue":"5","key":"10.1016\/j.biologicals.2025.101820_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/03079457.2018.1488240","article-title":"Newcastle disease virus: is an updated attenuated vaccine needed?","volume":"47","author":"Shahar","year":"2018","journal-title":"Avian Pathol"},{"issue":"2","key":"10.1016\/j.biologicals.2025.101820_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biologicals.2014.11.003","article-title":"Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines","volume":"43","author":"Cardenas-Garcia","year":"2015","journal-title":"Biologicals"},{"issue":"13","key":"10.1016\/j.biologicals.2025.101820_bib38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/ani12131696","article-title":"Genotype VII. 1.1-based Newcastle disease virus vaccines afford better protection against field isolates in commercial broiler chickens","volume":"12","author":"Dewidar","year":"2022","journal-title":"Animals"},{"key":"10.1016\/j.biologicals.2025.101820_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1482314","article-title":"Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII. 2) local isolates of Bangladesh","volume":"15","author":"Haque","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.biologicals.2025.101820_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.908459","article-title":"Comprehending B-cell epitope prediction to develop vaccines and immunodiagnostics","volume":"13","author":"Caoili","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.biologicals.2025.101820_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bj.2020.01.002","article-title":"Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein\u2013Barr virus","volume":"44","author":"Olotu","year":"2021","journal-title":"Biomed J"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105625000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105625000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:50:45Z","timestamp":1762354245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105625000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"alternative-id":["S1045105625000119"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2025.101820","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum reactivity analysis with inactivated GVII-matched vaccine\u2014Payavax G79\u00ae: Comparison of B-cell epitopes in NDV-vaccine strains","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2025.101820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101820"}}